Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from the ADA 2018 in Orlando.
Jeffrey Emmick MD, Ph.D is the vice president of product development at Eli Lilly and Company. Dr. Emmick has been with the organization for over 20 years in various roles. Currently, he is responsible for late-stage clinical development for the entire Lilly diabetes portfolio.
Featured videos include:
Pt.1: Lilly Diabetes New Research
Pt.2: Lilly Studies Combining GLP1 and SGLT2 Inhibitors
or view the complete interview here: Full Interview.